What is the estimated cost of generic Mirabegron?
The anticipated cost of generic Mirabegron is expected to be significantly lower than its brand-name counterpart, Myrbetriq. While exact pricing will vary by manufacturer and pharmacy, early indications suggest a substantial reduction. For example, early generic pricing indications showed a potential for savings of over 80% compared to the brand-name drug [1].
When did generic Mirabegron become available?
Generic versions of Mirabegron began entering the market following patent expirations and subsequent approvals by regulatory bodies. Reports in late 2023 and early 2024 indicated the availability of generic Mirabegron [1][2].
What factors influence the price of generic Mirabegron?
The price of generic Mirabegron is influenced by several market dynamics. The number of generic manufacturers entering the market plays a key role, as increased competition typically drives down prices. Supply chain factors, manufacturing costs, and the specific pricing strategies of individual generic drug companies also contribute to the final cost.
How does generic Mirabegron compare to brand-name Myrbetriq?
Generic Mirabegron offers the same active ingredient and is bioequivalent to brand-name Myrbetriq. This means it is expected to have the same therapeutic effect and safety profile. The primary difference is the cost, with generics generally being much more affordable [3].
Who makes generic Mirabegron?
Multiple pharmaceutical companies are expected to manufacture and distribute generic Mirabegron. As patents expire and regulatory approvals are granted, various generic drug manufacturers can enter the market. Information on specific manufacturers and their launch timelines can often be found through pharmaceutical industry tracking resources [1].
What is Mirabegron used to treat?
Mirabegron is used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency [4].
What is the patent status of Mirabegron?
Patents protecting Mirabegron have expired or are nearing expiration, paving the way for generic competition. DrugPatentWatch.com tracks patent information and expiry dates for pharmaceuticals, providing detailed insights into the patent landscape for drugs like Mirabegron [1].
Sources
1. https://drugpatentwatch.com/
2. Various pharmaceutical news outlets and generic drug availability announcements (specific links not provided in original text).
3. U.S. Food and Drug Administration (FDA) guidance on generics (general principle).
4. Drug labels and prescribing information for Myrbetriq (general information about the drug's indication).